Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Women Health ; 58(1): 112-127, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28095209

RESUMO

This study investigated the psychological factors related to the overlap syndrome, i.e., multiple gastrointestinal conditions that are part of functional gastrointestinal disorders (FGIDs) in the same individual and potentially related to quality of life (QOL) among women aged 45-60 years (n = 627) in South Korea. The study was undertaken between July 2014 and March 2015. Depressive and anxiety symptoms were ascertained using the Center for Epidemiologic Studies Depression scale (CES-D) and the Beck Anxiety Inventory (BAI), respectively. Negative cognition and the cognitive triad were identified using the Automatic Thoughts Questionnaire-Negative (ATQ-N) and the Cognitive Triad Inventory (CTI), respectively. Resilience and QOL were assessed using the Connor-Davidson Resilience Scale (CD-RISC) and World Health Organization Quality of Life scale abbreviated version (WHOQOL-BREF). Women with the overlap syndrome had the highest CES-D (mean = 16.66 ± 11.79, p < .001), BAI (mean = 17.46 ± 12.67, p < .001), and ATQ-N scores (mean = 53.61 ± 20.88, p < .001), followed by women with gastrointestinal disorders but without the overlap syndrome and healthy controls. Healthy controls had the highest WHOQOL-BREF score (mean = 77.69 ± 12.53, p < .001). After stepwise selection, the final model explained 61.8 percent of the variance in QOL. Thus, depressive symptoms, anxiety, negative cognition, cognitive triad, and resilience were significantly related to QOL in women with the overlap syndrome.


Assuntos
Ansiedade/psicologia , Depressão/psicologia , Gastroenteropatias/psicologia , Qualidade de Vida/psicologia , Resiliência Psicológica , Doenças do Tecido Conjuntivo Indiferenciado/psicologia , Ansiedade/diagnóstico , Ansiedade/epidemiologia , Estudos de Casos e Controles , Cognição , Depressão/diagnóstico , Depressão/epidemiologia , Feminino , Gastroenteropatias/diagnóstico , Gastroenteropatias/etnologia , Humanos , Pessoa de Meia-Idade , República da Coreia/epidemiologia , Inquéritos e Questionários , Doenças do Tecido Conjuntivo Indiferenciado/etnologia
2.
Lupus ; 27(2): 190-198, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28618891

RESUMO

Objective The objective of this study was to identify determinants of health-related quality of life (HRQoL) impairment in patients with systemic lupus erythematosus (SLE). Methods Overall, 101 SLE patients were recruited; 37 healthy subjects and 35 rheumatoid arthritis (RA) patients served as controls. HRQoL was evaluated using three patient reported outcomes (PROs): the Short Form-36 version 2 (SF-36v2) health survey, the fatigue scale version 4 (FACITv4) and the Heath Assessment Questionnaire (HAQ). A large set of demographic and clinical variables, including SLE arthritis subtypes, was evaluated searching for factors independently associated with worse QoL. Multivariate models were applied to identify factors independently associated with outcomes. Bonferroni's corrected p values < 0.05 were considered significant. Results SLE patients showed worse results than healthy controls ( p < 0.01) in all SF-36v2 domains and, with reference to the mental QoL, also than RA patients ( p < 0.01). Jaccoud's deformities, active arthritis, and fibromyalgia were the only factors independently associated with worse results in both physical and mental components summary of the SF-36v2 ( p < 0.01) and FACITv4 fatigue scale ( p < 0.01). Fragility fractures, deformities, and active arthritis negatively affected disability perception measured by the HAQ ( p < 0.01). No statistically significant differences in perceived HRQoL were highlighted between patients with deforming and erosive arthritis. However, they had significantly worse results than patients with non-deforming non-erosive arthritis across all investigated PROs ( p < 0.01). Conclusion In order to limit musculoskeletal manifestations as a source of impaired QoL in SLE patients, therapeutic strategies targeted to successfully manage active arthritis and fibromyalgia and to prevent deforming damage are needed.


Assuntos
Lúpus Eritematoso Sistêmico/psicologia , Doenças Musculoesqueléticas/psicologia , Qualidade de Vida/psicologia , Adulto , Idoso , Artrite Reumatoide/complicações , Artrite Reumatoide/psicologia , Artrite Reumatoide/terapia , Estudos Transversais , Feminino , Fibromialgia/complicações , Fibromialgia/psicologia , Fibromialgia/terapia , Humanos , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/diagnóstico , Masculino , Pessoa de Meia-Idade , Doenças Musculoesqueléticas/diagnóstico , Doenças Musculoesqueléticas/etiologia , Medidas de Resultados Relatados pelo Paciente , Estudos Prospectivos , Inquéritos e Questionários/normas , Doenças do Tecido Conjuntivo Indiferenciado/complicações , Doenças do Tecido Conjuntivo Indiferenciado/psicologia , Doenças do Tecido Conjuntivo Indiferenciado/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...